Jay Bradner, M.D., serves as Executive Vice President of Research and Development at Amgen, where he leads efforts in drug development with a focus on innovative therapies for childhood cancers. A physician-scientist based in Thousand Oaks, CA, Bradner combines clinical insight with biotech leadership to advance targeted and accessible medicines. His expertise in pharmaceutical R&D is recognized within the industry, supported by a strong professional network.

‌